Key facts
| Price (PPV) | 9,451 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | erlotinib |
| Class | Antineoplastic agents |
| ATC code | L01EB02 |
| Manufacturer | ROCHE S.A |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 9,274 MAD |
| Data collected on | 9/8/2026 |
Indications
Tarceva est indiqué dans le traitement de première ligne et d'entretien de patients souffrant de cancer du poumon non à petites cellules localement avancé ou métastatique (CBNPC) et présentant des mutations activatrices de l'EGFR. Tarceva est indiqué dans le traitement de patients souffrant de cancer du poumon non à petites cellules localement avancé ou métastatique, après échec d'au moins une chimiothérapie. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 3 other products contain the same active substance as Tarceva 150 mg (Erlotinib), at the same strength and in the same dosage form. For the same pack size (Boîte de 30), the cheapest is Erlotirel 150 mg (PHARMIS) at 6,943 MAD, i.e. 27 % less than Tarceva 150 mg (9,451 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Erlotirel 150 mg | PHARMIS | Boite de 30 | 6,943 MAD | 231.43 / unit | −27 % |
| Mirata 150 mg | PROMOPHARM (HIKMA) | Boite de 30 | 7,073 MAD | 235.77 / unit | −25 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Erluntas 150 mg | AMANYS PHARMA (Ex SAHAM PHARMA) | Flacon de 30 | 8,943 MAD | — |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Tarceva 150 mg
Tarceva 150 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by ROCHE S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Tarceva 150 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Tarceva 150 mg
Answers to common questions from Moroccan patients about this drug.